NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
Back to search
Official data from USPTO
VIRAX IMMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
02/04/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/14/2023
Registration date
02/03/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
02/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-11-00
First use in commerce
2024-11-00
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
BEGGS,MONICA L
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VIRAX BIOLABS (UK) LIMITED
Representatives
David W. Grace Loeb & Loeb LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Specimen collection kits for use in virus testing, namely, test kits for professional use comprised primarily of medical diagnostic reagents and assays and also including assay microplates used in diagnosis and assessment of adoptive immunity and post viral syndromes
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/14/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/14/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/04/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/28/2025
IUAF
USE AMENDMENT FILED
06/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2024
GNRT
NON-FINAL ACTION E-MAILED
10/10/2024
CNRT
NON-FINAL ACTION WRITTEN
10/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/12/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/12/2024
GNRT
NON-FINAL ACTION E-MAILED
03/12/2024
CNRT
NON-FINAL ACTION WRITTEN
03/12/2024
DOCK
ASSIGNED TO EXAMINER
03/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/18/2023
NWAP
NEW APPLICATION ENTERED
06/17/2023
Continuous trademark protection
Get notified about every new filing that threatens VIRAX IMMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.